id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-325669-6kjlcakt	Fogacci, Silvia	Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues	2020-09-10		.txt	text/plain	3373	186	38	The purpose of the current review is to highlight the safety of drug treatment for COVID -19 in pregnant women treated with anti-hypertensive medications. In accordance with the European Society of Cardiology (ESC) guidelines for the management of CV diseases during pregnancy, 100-150 mg/day acetylsalicylic acid (aspirin) should be recommended to pregnant women with a high or moderate risk to develop pre-eclampsia (class I; level of evidence A) [17] . In accordance with the American Heart Association (AHA) recommendations [25] , methyldopa should only be prescribed in cases of severe hypertension during pregnancy, considering potential maternal and fetal side effects (class I; level of evidence A). In accordance with the latest ESC guidelines for the management of CV disease during the COVID-19 pandemic, drug-drug interactions should be considered before administering azithromycin in patients treated with LMWH [37] , despite possible beneficial effects by azithromycin in patients infected with SARS-CoV-2 [48] .	./cache/cord-325669-6kjlcakt.txt	./txt/cord-325669-6kjlcakt.txt